News Medical on MSN
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Cambridge biotech Nuclera and Swiss company leadXpro have joined forces in a bid to fast-track membrane protein programmes.
Stacker on MSN
How AI is speeding up cancer research
Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting biomarker discovery.
News: BioAI at India AI Impact Summit outlined how AI+biology can accelerate biomanufacturing—using genomics, in-silico design, and data loops for scale and trust.
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...
Unilever PLC ( UL) Q4 2025 Earnings Call February 12, 2026 3:00 AM EST ...
From housewives with brooms to Olympic lifters - step inside the world-leading National Curling Academy in Stirling.
Q4 2025 Earnings Call February 11, 2026 7:30 AM ESTCompany ParticipantsCiaran Potts - Head of Investor RelationsAnthony P. J.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results